Haemocytometry in the management of infectious diseases such as COVID-19
Speaker
Prof. Andre van der Ven
Radboud University Nijmegen
The Netherlands
Prof van der Ven has been working in the field of infectious diseases, as a clinician, teacher, and researcher for more than 30 years. His clinical work covers 38 years of experience, including employment as a tropical doctor and a university internist- infectious diseases. He has dedicated his life’s work to basic and translational research, both in The Netherlands and in the low- and middle-income countries, and has supervised over 45 Ph.D. candidates from Europe, Africa, and Asia. The focus of his research and teaching is on the susceptibility and management of infectious diseases
Dr Joachim Linssen, PhD
Director Medical Scientific Department
Sysmex EMEA, Germany
Moderator
Prof. DR. Dr. Ida Parwati, Sp.PK(K), Ph.D
Dr. Hasan Sadikin General Hospital
Bandung, West Java, Indonesia
Abstract of Lecture
New generation haematology analysers have improved capacity to detect phenotypical changes in leukocyte subsets, leading to a more comprehensive panel of blood cell makers. A combination of classic haemocytometric parameters, combined with the new innovative markers, may be used to build algorithms to differentiate causes of infectious diseases or develop scores to differentiate patients with severe disease from those with more favorable prognosis. For instance, haemocytometric changes in COVID-19 patients that eventually need intensive care treatment are different from those that can be managed conservatively: a principle used to develop a prognostic score based on an algorithm of haemocytometric parameters. In the webinar, the process underlying the new techniques are explained, with an overview of the new parameters given and how they can be used in infectious diseases, such as COVID-19.
We hope you have enjoyed the webinar and gained new insights!
May we request your time for a short survey?